Muhammad Wasif Saif

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

Howard S. Höchster, Lowell L. Hart, Ramesh K. Ramanathan et al. · Journal of Clinical Oncology · 2008 · 620 citations

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

Philip A. Philip, Jill Lacy, Fabienne Portales et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 227 citations

Open-label Phase 2, Pancreatic Cancer, Gastrointestinal Oncology +7

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Hans‐Joachim Schmoll, Chris Twelves, Weijing Sun et al. · The Lancet Oncology · 2014 · 166 citations · Full text

Gastrointestinal Oncology, Medicine, Individual Patient Data +7

Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity

Wen Wee, Muhammad Wasif Saif, Bassel F. El‐Rayes et al. · Cancer · 2016 · 119 citations · Full text